These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27456080)

  • 21. Comparison of the prediction performance of different warfarin dosing algorithms based on Chinese patients.
    Xie C; Xue L; Zhang Y; Zhu J; Zhou L; Hang Y; Ding X; Jiang B; Miao L
    Pharmacogenomics; 2020 Jan; 21(1):23-32. PubMed ID: 31849278
    [No Abstract]   [Full Text] [Related]  

  • 22. Stable warfarin dose prediction in sub-Saharan African patients: A machine-learning approach and external validation of a clinical dose-initiation algorithm.
    Asiimwe IG; Blockman M; Cohen K; Cupido C; Hutchinson C; Jacobson B; Lamorde M; Morgan J; Mouton JP; Nakagaayi D; Okello E; Schapkaitz E; Sekaggya-Wiltshire C; Semakula JR; Waitt C; Zhang EJ; Jorgensen AL; Pirmohamed M
    CPT Pharmacometrics Syst Pharmacol; 2022 Jan; 11(1):20-29. PubMed ID: 34889080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial of genotype-based Coumadin initiation.
    Burmester JK; Berg RL; Yale SH; Rottscheit CM; Glurich IE; Schmelzer JR; Caldwell MD
    Genet Med; 2011 Jun; 13(6):509-18. PubMed ID: 21423021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized controlled trial of genotype-guided warfarin anticoagulation in Chinese elderly patients with nonvalvular atrial fibrillation.
    Zhu Y; Xu C; Liu J
    J Clin Pharm Ther; 2020 Dec; 45(6):1466-1473. PubMed ID: 32710457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pharmacogenetic versus a clinical algorithm for warfarin dosing.
    Kimmel SE; French B; Kasner SE; Johnson JA; Anderson JL; Gage BF; Rosenberg YD; Eby CS; Madigan RA; McBane RB; Abdel-Rahman SZ; Stevens SM; Yale S; Mohler ER; Fang MC; Shah V; Horenstein RB; Limdi NA; Muldowney JA; Gujral J; Delafontaine P; Desnick RJ; Ortel TL; Billett HH; Pendleton RC; Geller NL; Halperin JL; Goldhaber SZ; Caldwell MD; Califf RM; Ellenberg JH;
    N Engl J Med; 2013 Dec; 369(24):2283-93. PubMed ID: 24251361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients.
    Cho SM; Lee KY; Choi JR; Lee KA
    Yonsei Med J; 2016 May; 57(3):635-40. PubMed ID: 26996562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.
    Marcatto LR; Sacilotto L; Bueno CT; Facin M; Strunz CM; Darrieux FC; Scanavacca MI; Krieger JE; Pereira AC; Santos PC
    BMC Cardiovasc Disord; 2016 Nov; 16(1):224. PubMed ID: 27855643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of pharmacogenetic algorithm for warfarin dose requirements in Japanese patients.
    Takeuchi F; Kashida M; Okazaki O; Tanaka Y; Fukuda S; Kashima T; Hosaka S; Hiroe M; Kimura S; Kato N
    Circ J; 2010 May; 74(5):977-82. PubMed ID: 20339191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.
    Siguret V; Gouin I; Debray M; Perret-Guillaume C; Boddaert J; Mahé I; Donval V; Seux ML; Romain-Pilotaz M; Gisselbrecht M; Verny M; Pautas E
    Am J Med; 2005 Feb; 118(2):137-42. PubMed ID: 15694897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients.
    Meckley LM; Wittkowsky AK; Rieder MJ; Rettie AE; Veenstra DL
    Thromb Haemost; 2008 Aug; 100(2):229-39. PubMed ID: 18690342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.
    Higashi MK; Veenstra DL; Kondo LM; Wittkowsky AK; Srinouanprachanh SL; Farin FM; Rettie AE
    JAMA; 2002 Apr; 287(13):1690-8. PubMed ID: 11926893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and comparison of a new personalized warfarin stable dose prediction algorithm in Chinese patients undergoing heart valve replacement.
    Tan SL; Li Z; Song GB; Liu LM; Zhang W; Peng J; Zhang T; Jia FF; Zhou G; Zhou HH; Zhou XM
    Pharmazie; 2012 Nov; 67(11):930-7. PubMed ID: 23210243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population.
    Tavares LC; Duarte NE; Marcatto LR; Soares RAG; Krieger JE; Pereira AC; Santos PCJL
    Eur J Clin Pharmacol; 2018 Dec; 74(12):1555-1566. PubMed ID: 30051215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Dowd MB; Subherwal S; Deych E; Eby CS; King CR; Porche-Sorbet RM; Murphy CV; Marchand R; Millican EA; Barrack RL; Clohisy JC; Kronquist K; Gatchel SK; Gage BF
    J Thromb Haemost; 2008 Oct; 6(10):1655-62. PubMed ID: 18662264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events.
    Chen SY; Wu N; Gulseth M; LaMori J; Bookhart BK; Boulanger L; Fields L; Schein J
    J Manag Care Pharm; 2013 May; 19(4):291-301. PubMed ID: 23627575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics.
    Fihn SD; Callahan CM; Martin DC; McDonell MB; Henikoff JG; White RH
    Ann Intern Med; 1996 Jun; 124(11):970-9. PubMed ID: 8624064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy.
    Horne BD; Lenzini PA; Wadelius M; Jorgensen AL; Kimmel SE; Ridker PM; Eriksson N; Anderson JL; Pirmohamed M; Limdi NA; Pendleton RC; McMillin GA; Burmester JK; Kurnik D; Stein CM; Caldwell MD; Eby CS; Rane A; Lindh JD; Shin JG; Kim HS; Angchaisuksiri P; Glynn RJ; Kronquist KE; Carlquist JF; Grice GR; Barrack RL; Li J; Gage BF
    Thromb Haemost; 2012 Feb; 107(2):232-40. PubMed ID: 22186998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation.
    Stam-Slob MC; Connolly SJ; van der Graaf Y; van der Leeuw J; Dorresteijn JAN; Eikelboom JW; Peters RJG; Alings M; Visseren FLJ
    Circulation; 2019 Jun; 139(25):2846-2856. PubMed ID: 31046423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total Thrombus-Formation Analysis System (T-TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    Ito M; Kaikita K; Sueta D; Ishii M; Oimatsu Y; Arima Y; Iwashita S; Takahashi A; Hoshiyama T; Kanazawa H; Sakamoto K; Yamamoto E; Tsujita K; Yamamuro M; Kojima S; Hokimoto S; Yamabe H; Ogawa H
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).
    Epstein RS; Moyer TP; Aubert RE; O Kane DJ; Xia F; Verbrugge RR; Gage BF; Teagarden JR
    J Am Coll Cardiol; 2010 Jun; 55(25):2804-12. PubMed ID: 20381283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.